Yujiro S. Hata - 19 Aug 2021 Form 3 Insider Report for ENANTA PHARMACEUTICALS INC (ENTA)

Role
Director
Signature
/s/ Nathaniel S. Gardiner as attorney-in-fact
Issuer symbol
ENTA
Transactions as of
19 Aug 2021
Net transactions value
$0
Form type
3
Filing time
23 Aug 2021, 16:38:50 UTC
Previous filing
25 Jun 2021
Next filing
02 Mar 2022

No securities are beneficially owned.

Remarks:

Exhibit 24 Power of Attorney filed herewith.